Clinical Trial Registration and Results Disclosure: Business Process Considerations
Teden, P.
Drug Information Journal 44(3): 243-251
2010
ISSN/ISBN: 0092-8615 DOI: 10.1177/009286151004400306
Accession: 082448150
Full-Text Article emailed within 0-6 h
Payments are secure & encrypted
References
Munshi, R.; Pilliwar, C.; Maurya, M.R. 2023: Public disclosure of clinical trial results at Clinical Trial Registry of India- Need for transparency in research! Perspectives in Clinical Research 14(2): 81-85Krleža-Jeriç, K.; Lemmens, T.; Reveiz, L.; Cuervo, L.Gabriel.; Bero, L.Anne. 2011: Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency Revista Panamericana de Salud Publica 30(1): 87-96
Grimshaw, J.M.; Presseau, J.; Tetroe, J.; Eccles, M.P.; Francis, J.J.; Godin, G.; Graham, I.D.; Hux, J.E.; Johnston, M.; Légaré, F.; Lemyre, L.; Robinson, N.; Zwarenstein, M. 2014: Looking inside the black box: results of a theory-based process evaluation exploring the results of a randomized controlled trial of printed educational messages to increase primary care physicians' diabetic retinopathy referrals [Trial registration number ISRCTN72772651 Implementation Science: Is 9: 86
Rockhold, F.W.; Freeman, A.J.; Metz, C.A. 2009: Public Disclosure of Clinical Trial Results Pharmaceutical Medicine 23(3): 131-137
Denne, S.C. 2012: Pediatric clinical trial registration and trial results: an urgent need for improvement Pediatrics 129(5): E1320-E1321
Oakley, J. 2009: Respecting participant autonomy and the disclosure of clinical trial results American Journal of Bioethics: Ajob 9(8): 38
Rogawski, M.A.; Federoff, H.J. 2011: Disclosure of clinical trial results when product development is abandoned Science Translational Medicine 3(102): 102cm29
Sarradoneck, A.; Sakoyan, J.; Desclaux, A.; Mancini, J.; Genre, D.; Julianreynier, C. 2012: They should take time: Disclosure of clinical trial results as part of a social relationship Social Science and Medicine (1982) 75(5): 873-882
Sarradon-Eck, A.; Sakoyan, J.; Desclaux, A.; Mancini, J.; Genre, D.; Julian-Reynier, C. 2012: "They should take time": disclosure of clinical trial results as part of a social relationship Social Science and Medicine 75(5): 873-882
Callen, J.P.; Robinson, J. 2005: Clinical trial registration: a step forward in providing transparency for the positive and negative results of clinical trials Archives of Dermatology 141(1): 75
Jennings, D.; Eberly, S.; Oakes, D.; Seibyl, J.; Marek, K.; Shoulson, I.; Fahn, S.; Gauger, L.; Marek, K.; Seibyl, J.; Goetz, C.; Lang, A.; Shoulson, I.; Oakes, D.; Flagg, E.; Rudolph, A.; Shinaman, A.; Kamp, C.; Kieburtz, K.; Molho, E.; Shill, H.; Stacy, M.; Jankovic, J.; Tarsy, D.; Paul, L.; DiRocco, A.; Sudarsky, L.; Panisset, M.; Galvez-Jimenez, N.; Subramanian, T.; Seeberger, L.; Waters, C.; Peterson, C.; Scott, B.; Chouinard, S.; Wojcieszek, J.; Jennings, D.; Fussell, B.; Savitt, J.; Gerstenhaber, M.; Jog, M.; Gordon, M.F.; Zweig, R.; Feldt, R.; Schwarzschild, M.; Tennis, M.; Uitti, R.; Sethi, K.; Elmer, L.; Friedman, J.; Feigin, A.; Simuni, T.; Grimes, D.; Mortensen, M.; Manyam, B.; Bronte-Stewart, H.; Mark, M.; Camicioli, R.; Suchow 2014: Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trial Journal of Parkinson's Disease 4(4): 629-638
Vernillo, A. 2009: Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies? American Journal of Bioethics: Ajob 9(8): 45-47
Dickersin, K.; Garcia-Lopez, F. 1992: Regulatory process effects clinical trial registration in Spain Controlled Clinical Trials 13(6): 507-512
D'Alonzo, G.E. 2004: Clinical trial registration, a needed addition to the research process Journal of the American Osteopathic Association 104(10): 409-410
Moorthy, V.S.; Karam, G.; Vannice, K.S.; Kieny, M-Paule. 2015: Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results Plos Medicine 12(4): E1001819
Herder, M. 2012: Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results Cmaj: Canadian Medical Association Journal 184(2): 194-199
Zarin, D.A.; Tse, T.; Sheehan, J. 2015: The proposed rule for U.S. clinical trial registration and results submission New England Journal of Medicine 372(2): 174-180
Jouni, H.; Haddad, R.A.; Marroush, T.S.; Brown, S.-A.; Kruisselbrink, T.M.; Austin, E.E.; Shameer, K.; Behnken, E.M.; Chaudhry, R.; Montori, V.M.; Kullo, I.J. 2017: Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 65(3): 681-688
Cohen, K.; Cormier, J.W.; Davar, M.V. 2013: Predictable materiality: a need for common criteria governing the disclosure of clinical trial results by publicly-traded pharmaceutical companies Journal of Contemporary Health Law and Policy 29(2): 201-232
Rawal, B.; Deane, B.R. 2014: Clinical trial transparency: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved recently in Europe Current Medical Research and Opinion 30(3): 395-405